---
figid: PMC8883485__BCJ-479-525-g0002
figtitle: FoxO transcription factors regulate mitochondrial biogenesis
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8883485
filename: BCJ-479-525-g0002.jpg
figlink: /pmc/articles/PMC8883485/figure/BCJ-479-525F2/
number: F2
caption: (A) In the liver, FoxO1 may induce Hmox1, Fxn, and Urod, which disrupt mitochondrial
  ETC and NAD/NADH ratio, thereby suppressing NAD-dependent Sirt1-Pgc1α-NRF1-Tfam
  pathway in mitochondrial biogenesis. Glucagon activated FoxO1 represses NRF1 and
  accounts for reduced mitochondrial biogenesis in the liver. (B) In contrast with
  the liver, FoxO1 induces Cyb5r3 and maintains ETC activity and NAD/NADH ratio in
  the pancreas. It is unclear but of interest whether the FoxO1–Cyb5r3 axis regulates
  mitochondrial biogenesis via the known NAD-dependent Sirt1-Pgc1α-NRF1-Tfam pathway
  (indicated by question marks). (C) In the heart, FoxO1 activation due to diabetes
  causes mitochondrial abnormality by dysregulating PDK4 and CPT1 via a to-be-defined
  mechanism (indicated by question marks). (D) In cancer cells, FoxO3 suppresses mitochondrial
  biogenesis and function by inhibiting c-Myc/Tfam signaling cascade.
papertitle: FoxO transcription factors in mitochondrial homeostasis.
reftext: Zhiyong Cheng. Biochem J. 2022 Feb 25;479(4):525-536.
year: '2022'
doi: 10.1042/BCJ20210777
journal_title: Biochemical Journal
journal_nlm_ta: Biochem J
publisher_name: Portland Press Ltd.
keywords: autophagy | FoxO | fusion and fission | homeostasis | mitochondrial biogenesis
  | mitophagy
automl_pathway: 0.9646407
figid_alias: PMC8883485__F2
figtype: Figure
redirect_from: /figures/PMC8883485__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8883485__BCJ-479-525-g0002.html
  '@type': Dataset
  description: (A) In the liver, FoxO1 may induce Hmox1, Fxn, and Urod, which disrupt
    mitochondrial ETC and NAD/NADH ratio, thereby suppressing NAD-dependent Sirt1-Pgc1α-NRF1-Tfam
    pathway in mitochondrial biogenesis. Glucagon activated FoxO1 represses NRF1 and
    accounts for reduced mitochondrial biogenesis in the liver. (B) In contrast with
    the liver, FoxO1 induces Cyb5r3 and maintains ETC activity and NAD/NADH ratio
    in the pancreas. It is unclear but of interest whether the FoxO1–Cyb5r3 axis regulates
    mitochondrial biogenesis via the known NAD-dependent Sirt1-Pgc1α-NRF1-Tfam pathway
    (indicated by question marks). (C) In the heart, FoxO1 activation due to diabetes
    causes mitochondrial abnormality by dysregulating PDK4 and CPT1 via a to-be-defined
    mechanism (indicated by question marks). (D) In cancer cells, FoxO3 suppresses
    mitochondrial biogenesis and function by inhibiting c-Myc/Tfam signaling cascade.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TFAM
  - NRF1
  - NFE2L1
  - PPARGC1A
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - SIRT1
  - CYB5R3
  - FXN
  - UROD
  - HMOX1
  - PDK4
  - CPT1A
  - CPT2
  - CHPT1
  - MYC
---
